topicMyo-Inositol Metabolic Syndrome Meta-Analysis
claimThe term polycystic ovary syndrome (PCOS) has traditionally been used in international evidence-based guidelines, including the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS [].
evidence level3
citationYanachkova Vesselina (2026)
sourceComparative Effects of Myo-Inositol, Metformin, Berberine, and Combination Therapy on Metabolic, Anthropometric and Hormonal Parameters in Women with Polycystic Ovary Syndrome: A 6-Month Observational Cohort Study
topicMyo-Inositol Metabolic Syndrome Meta-Analysis
claimIn addition, disorders in insulin signaling have a significant impact on glucose metabolism, adipose tissue, and energy balance, which determines the increased risk of metabolic complications in these patients [,,,].
evidence level3
citationYanachkova Vesselina (2026)
sourceComparative Effects of Myo-Inositol, Metformin, Berberine, and Combination Therapy on Metabolic, Anthropometric and Hormonal Parameters in Women with Polycystic Ovary Syndrome: A 6-Month Observational Cohort Study
topicMyo-Inositol Metabolic Syndrome Meta-Analysis
claimIn this regard, metabolic risk assessment should be an integral part of the diagnostic process in all patients with PCOS regardless of their phenotype.
evidence level3
citationYanachkova Vesselina (2026)
sourceComparative Effects of Myo-Inositol, Metformin, Berberine, and Combination Therapy on Metabolic, Anthropometric and Hormonal Parameters in Women with Polycystic Ovary Syndrome: A 6-Month Observational Cohort Study
topicMyo-Inositol Metabolic Syndrome Meta-Analysis
claim1 2 3 4 Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age, with a prevalence ranging from 6% to 20%, depending on the diagnostic criteria applied.
evidence level3
citationYanachkova Vesselina (2026)
sourceComparative Effects of Myo-Inositol, Metformin, Berberine, and Combination Therapy on Metabolic, Anthropometric and Hormonal Parameters in Women with Polycystic Ovary Syndrome: A 6-Month Observational Cohort Study
topicMyo-Inositol Metabolic Syndrome Meta-Analysis
claim1 2 The quest for the best strategy to apply in cases of overweight, obesity, metabolic alterations, and increased cardiovascular risk has challenged scientists for decades.
evidence level4
citationRicottini Lucilla (2024)
sourceThe Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome
topicMyo-Inositol Metabolic Syndrome Meta-Analysis
claimThis has contributed to an increased incidence of overweight, inflammation, and metabolic disruption, with all their well-known consequences.
evidence level4
citationRicottini Lucilla (2024)
sourceThe Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome
topicMyo-Inositol Metabolic Syndrome Meta-Analysis
claimIt is now predicted that, by 2050, the prevalence of type 2 diabetes mellitus (T2DM) will rise dramatically and that the mortality risk for all causes will increase in proportion with increases in body mass index (BMI) [,].
evidence level4
citationRicottini Lucilla (2024)
sourceThe Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome
topicMyo-Inositol Metabolic Syndrome Meta-Analysis
claimThis is due, at least in part, to our ability to store energy without limits, even if it is not needed, as well as our unrestricted access to commercially available food sources.
evidence level4
citationRicottini Lucilla (2024)
sourceThe Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome